| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.60B | +7.3% |
| Cost of Revenue | $4.21B | +5.2% |
| R&D Expense | $220.8M | +11.1% |
| SG&A Expense | $677.0M | +5.0% |
| Operating Income | $1.71B | +13.8% |
| Interest Expense | $81.8M | -1.7% |
| Pre-tax Income | $1.61B | +12.4% |
| Income Tax | $293.2M | +8.9% |
| Net Income | $1.31B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $409.8M | +18.7% |
| Accounts Receivable | $1.01B | +10.2% |
| Inventory | $1.13B | +8.4% |
| Current Assets | $2.82B | +11.7% |
| Total Assets | $15.02B | +20.9% |
| Current Liabilities | $2.88B | +84.3% |
| Long-term Debt | $3.31B | +38.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.74B | +51.0% |
| Capital Expenditures | $136.2M | -2.0% |
| Investing Cash Flow | -$2.38B | -329.9% |
| Financing Cash Flow | $697.3M | +221.1% |
| Free Cash Flow | $1.60B | +58.3% |
| +13.3% |
| EPS (Basic) | $5.70 | +13.1% |
| EPS (Diluted) | $5.67 | +13.2% |
| Total Liabilities |
| $6.29B |
| +27.0% |
| Stockholders' Equity | $8.73B | +16.8% |